生物性骨材全球市場 2024-2028
市場調查報告書
商品編碼
1544209

生物性骨材全球市場 2024-2028

Global Orthobiologics Market 2024-2028

出版日期: | 出版商: TechNavio | 英文 180 Pages | 訂單完成後即時交付

價格

預計 2023 年至 2028 年,生物性骨材市場將成長 27.68 億美元,預測期內複合年成長率為 7.75%。

該報告包括對生物性骨材市場的總體分析、市場規模和預測、趨勢、成長促進因素、挑戰以及涵蓋約 25 家供應商的供應商分析。

它提供了對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。隨著人口老化,整形外科疾病日益流行,人們對減少整形外科手術的興趣日益濃厚,以及生物性骨材製品的核准和批准不斷增加,推動了市場的發展。

市場範圍
基準年 2024年
結束年份 2028年
預測期 2024-2028
成長動力 加速度
2024年與前一年同期比較 7.19%
複合年成長率 7.75%
增量 27.68億美元

研究指出,新產品市場的持續開發是未來幾年推動生物性骨材市場成長的關鍵因素之一。此外,新技術創新和生物性骨材的日益普及導致了巨大的市場需求。

目錄

第1章執行摘要

  • 市場概況

第2章 市場狀況

  • 市場生態系統
  • 市場特徵
  • 價值鏈分析

第3章 市場規模評估

  • 市場定義
  • 細分市場分析
  • 2023 年市場規模
  • 2023-2028年市場展望

第4章 市場規模表現

  • 生物性骨材全球市場 2018-2022
  • 2018-2022 年按應用分類的細分市場分析
  • 2018-2022 年按產品細分分析
  • 2018-2022 年區域細分分析
  • 2018-2022 年國家細分分析

第5章五力分析

  • 五力摘要
  • 買方議價能力
  • 供應商的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭威脅
  • 市場狀況

第6章市場細分:按應用

  • 市場區隔
  • 比較:按應用
  • 脊椎融合手術:2023-2028年市場規模與預測
  • 重組手術:2023-2028 年市場規模與預測
  • 創傷修復:2023-2028 年市場規模與預測
  • 其他:2023-2028年市場規模與預測
  • 市場機會:依應用分類

第7章市場區隔:依產品

  • 市場區隔
  • 比較:按產品
  • 骨移植替代品:2023-2028 年市場規模與預測
  • 關節內粘稠補充療法:2023-2028年市場規模與預測
  • 幹細胞:市場規模及2023-2028年預測
  • 市場機會:依產品分類

第8章 客戶狀況

  • 客戶狀況概覽

第9章 地區情勢

  • 區域細分
  • 區域比較
  • 北美:2023-2028 年市場規模與預測
  • 歐洲:2023-2028 年市場規模與預測
  • 亞洲:2023-2028年市場規模與預測
  • 世界其他地區:2023-2028 年市場規模與預測
  • 美國:2023-2028 年市場規模與預測
  • 英國:2023-2028 年市場規模與預測
  • 中國:2023-2028年市場規模及預測
  • 德國:2023-2028年市場規模與預測
  • 加拿大:2023-2028 年市場規模與預測
  • 市場機會:依地區狀況

第10章 促進因素、挑戰、機會、限制因素

  • 市場促進因素
  • 市場挑戰
  • 促進因素和挑戰的影響
  • 市場機會與限制

第11章競爭格局

  • 概述
  • 競爭格局
  • 混亂的情況
  • 產業風險

第12章 競爭分析

  • 公司簡介
  • 公司市場定位
  • Advanced Medical Solutions Group Plc
  • Anika Therapeutics Inc.
  • Arthrex Inc.
  • Bioventus LLC
  • Globus Medical Inc.
  • Institut Straumann AG
  • Johnson and Johnson Services Inc.
  • Medtronic Plc
  • Nuvasive Inc.
  • Orthofix Medical Inc.
  • OrthoPediatrics Corp.
  • ROYAL BIOLOGICS
  • RTI Surgical Inc.
  • Smith and Nephew plc
  • Stryker Corp.

第13章附錄

Product Code: IRTNTR70811

The orthobiologics market is forecasted to grow by USD 2768 mn during 2023-2028, accelerating at a CAGR of 7.75% during the forecast period. The report on the orthobiologics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of orthopedic disorders coupled with an aging population, increase in focus to reduce orthopedic surgeries, and rise in approvals and clearances for orthobiologics products.

Technavio's orthobiologics market is segmented as below:

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20247.19%
CAGR7.75%
Incremental Value$2768 mn

By Application

    • Spinal fusion
    • Reconstructive surgery
    • Trauma repair
    • Others

By Product

    • Bone graft substitutes
    • Viscosupplementation
    • Stem cells

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the increase in development of new products as one of the prime reasons driving the orthobiologics market growth during the next few years. Also, emerging technological innovations and rise in popularity of orthobiologics will lead to sizable demand in the market.

The report on the orthobiologics market covers the following areas:

    • Orthobiologics market sizing
    • Orthobiologics market forecast
    • Orthobiologics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading orthobiologics market vendors that include Advanced Medical Solutions Group Plc, Anika Therapeutics Inc., Arthrex Inc., Bioventus LLC, Globus Medical Inc., Institut Straumann AG, Integra Lifesciences Corp., Johnson and Johnson Services Inc., Kuros Biosciences AG, Medtronic Plc, MTF Biologics, Nuvasive Inc., Orthofix Medical Inc., OrthoPediatrics Corp., ROYAL BIOLOGICS, RTI Surgical Inc., Smith and Nephew plc, Stryker Corp., Xtant Medical Holdings Inc., and Zimmer Biomet Holdings Inc.. Also, the orthobiologics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Market Segmentation by Product
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ million)
    • Data Table on Global - Market size and forecast 2023-2028 ($ million)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global Orthobiologics Market 2018 - 2022
    • Historic Market Size - Data Table on Global Orthobiologics Market 2018 - 2022 ($ million)
  • 4.2 Application segment analysis 2018 - 2022
    • Historic Market Size - Application Segment 2018 - 2022 ($ million)
  • 4.3 Product segment analysis 2018 - 2022
    • Historic Market Size - Product Segment 2018 - 2022 ($ million)
  • 4.4 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 4.5 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

  • 6.1 Market segments
    • Chart on Application - Market share 2023-2028 (%)
    • Data Table on Application - Market share 2023-2028 (%)
  • 6.2 Comparison by Application
    • Chart on Comparison by Application
    • Data Table on Comparison by Application
  • 6.3 Spinal fusion - Market size and forecast 2023-2028
    • Chart on Spinal fusion - Market size and forecast 2023-2028 ($ million)
    • Data Table on Spinal fusion - Market size and forecast 2023-2028 ($ million)
    • Chart on Spinal fusion - Year-over-year growth 2023-2028 (%)
    • Data Table on Spinal fusion - Year-over-year growth 2023-2028 (%)
  • 6.4 Reconstructive surgery - Market size and forecast 2023-2028
    • Chart on Reconstructive surgery - Market size and forecast 2023-2028 ($ million)
    • Data Table on Reconstructive surgery - Market size and forecast 2023-2028 ($ million)
    • Chart on Reconstructive surgery - Year-over-year growth 2023-2028 (%)
    • Data Table on Reconstructive surgery - Year-over-year growth 2023-2028 (%)
  • 6.5 Trauma repair - Market size and forecast 2023-2028
    • Chart on Trauma repair - Market size and forecast 2023-2028 ($ million)
    • Data Table on Trauma repair - Market size and forecast 2023-2028 ($ million)
    • Chart on Trauma repair - Year-over-year growth 2023-2028 (%)
    • Data Table on Trauma repair - Year-over-year growth 2023-2028 (%)
  • 6.6 Others - Market size and forecast 2023-2028
    • Chart on Others - Market size and forecast 2023-2028 ($ million)
    • Data Table on Others - Market size and forecast 2023-2028 ($ million)
    • Chart on Others - Year-over-year growth 2023-2028 (%)
    • Data Table on Others - Year-over-year growth 2023-2028 (%)
  • 6.7 Market opportunity by Application
    • Market opportunity by Application ($ million)
    • Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Product

  • 7.1 Market segments
    • Chart on Product - Market share 2023-2028 (%)
    • Data Table on Product - Market share 2023-2028 (%)
  • 7.2 Comparison by Product
    • Chart on Comparison by Product
    • Data Table on Comparison by Product
  • 7.3 Bone graft substitutes - Market size and forecast 2023-2028
    • Chart on Bone graft substitutes - Market size and forecast 2023-2028 ($ million)
    • Data Table on Bone graft substitutes - Market size and forecast 2023-2028 ($ million)
    • Chart on Bone graft substitutes - Year-over-year growth 2023-2028 (%)
    • Data Table on Bone graft substitutes - Year-over-year growth 2023-2028 (%)
  • 7.4 Viscosupplementation - Market size and forecast 2023-2028
    • Chart on Viscosupplementation - Market size and forecast 2023-2028 ($ million)
    • Data Table on Viscosupplementation - Market size and forecast 2023-2028 ($ million)
    • Chart on Viscosupplementation - Year-over-year growth 2023-2028 (%)
    • Data Table on Viscosupplementation - Year-over-year growth 2023-2028 (%)
  • 7.5 Stem cells - Market size and forecast 2023-2028
    • Chart on Stem cells - Market size and forecast 2023-2028 ($ million)
    • Data Table on Stem cells - Market size and forecast 2023-2028 ($ million)
    • Chart on Stem cells - Year-over-year growth 2023-2028 (%)
    • Data Table on Stem cells - Year-over-year growth 2023-2028 (%)
  • 7.6 Market opportunity by Product
    • Market opportunity by Product ($ million)
    • Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ million)
    • Data Table on North America - Market size and forecast 2023-2028 ($ million)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ million)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ million)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ million)
    • Data Table on US - Market size and forecast 2023-2028 ($ million)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ million)
    • Data Table on UK - Market size and forecast 2023-2028 ($ million)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.9 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ million)
    • Data Table on China - Market size and forecast 2023-2028 ($ million)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.10 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ million)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.11 Canada - Market size and forecast 2023-2028
    • Chart on Canada - Market size and forecast 2023-2028 ($ million)
    • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
    • Chart on Canada - Year-over-year growth 2023-2028 (%)
    • Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market opportunities/restraints

11 Competitive Landscape

  • 11.1 Overview
  • 11.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 11.3 Landscape disruption
    • Overview on factors of disruption
  • 11.4 Industry risks
    • Impact of key risks on business

12 Competitive Analysis

  • 12.1 Companies profiled
    • Companies covered
  • 12.2 Market positioning of companies
    • Matrix on companies position and classification
  • 12.3 Advanced Medical Solutions Group Plc
    • Advanced Medical Solutions Group Plc - Overview
    • Advanced Medical Solutions Group Plc - Business segments
    • Advanced Medical Solutions Group Plc - Key news
    • Advanced Medical Solutions Group Plc - Key offerings
    • Advanced Medical Solutions Group Plc - Segment focus
  • 12.4 Anika Therapeutics Inc.
    • Anika Therapeutics Inc. - Overview
    • Anika Therapeutics Inc. - Product / Service
    • Anika Therapeutics Inc. - Key news
    • Anika Therapeutics Inc. - Key offerings
  • 12.5 Arthrex Inc.
    • Arthrex Inc. - Overview
    • Arthrex Inc. - Product / Service
    • Arthrex Inc. - Key offerings
  • 12.6 Bioventus LLC
    • Bioventus LLC - Overview
    • Bioventus LLC - Business segments
    • Bioventus LLC - Key news
    • Bioventus LLC - Key offerings
    • Bioventus LLC - Segment focus
  • 12.7 Globus Medical Inc.
    • Globus Medical Inc. - Overview
    • Globus Medical Inc. - Product / Service
    • Globus Medical Inc. - Key offerings
  • 12.8 Institut Straumann AG
    • Institut Straumann AG - Overview
    • Institut Straumann AG - Business segments
    • Institut Straumann AG - Key news
    • Institut Straumann AG - Key offerings
    • Institut Straumann AG - Segment focus
  • 12.9 Johnson and Johnson Services Inc.
    • Johnson and Johnson Services Inc. - Overview
    • Johnson and Johnson Services Inc. - Business segments
    • Johnson and Johnson Services Inc. - Key news
    • Johnson and Johnson Services Inc. - Key offerings
    • Johnson and Johnson Services Inc. - Segment focus
  • 12.10 Medtronic Plc
    • Medtronic Plc - Overview
    • Medtronic Plc - Business segments
    • Medtronic Plc - Key news
    • Medtronic Plc - Key offerings
    • Medtronic Plc - Segment focus
  • 12.11 Nuvasive Inc.
    • Nuvasive Inc. - Overview
    • Nuvasive Inc. - Business segments
    • Nuvasive Inc. - Key offerings
    • Nuvasive Inc. - Segment focus
  • 12.12 Orthofix Medical Inc.
    • Orthofix Medical Inc. - Overview
    • Orthofix Medical Inc. - Business segments
    • Orthofix Medical Inc. - Key news
    • Orthofix Medical Inc. - Key offerings
    • Orthofix Medical Inc. - Segment focus
  • 12.13 OrthoPediatrics Corp.
    • OrthoPediatrics Corp. - Overview
    • OrthoPediatrics Corp. - Business segments
    • OrthoPediatrics Corp. - Key offerings
    • OrthoPediatrics Corp. - Segment focus
  • 12.14 ROYAL BIOLOGICS
    • ROYAL BIOLOGICS - Overview
    • ROYAL BIOLOGICS - Product / Service
    • ROYAL BIOLOGICS - Key offerings
  • 12.15 RTI Surgical Inc.
    • RTI Surgical Inc. - Overview
    • RTI Surgical Inc. - Product / Service
    • RTI Surgical Inc. - Key offerings
  • 12.16 Smith and Nephew plc
    • Smith and Nephew plc - Overview
    • Smith and Nephew plc - Business segments
    • Smith and Nephew plc - Key news
    • Smith and Nephew plc - Key offerings
    • Smith and Nephew plc - Segment focus
  • 12.17 Stryker Corp.
    • Stryker Corp. - Overview
    • Stryker Corp. - Business segments
    • Stryker Corp. - Key news
    • Stryker Corp. - Key offerings
    • Stryker Corp. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 13.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 13.4 Research methodology
    • Research methodology
  • 13.5 Data procurement
    • Information sources
  • 13.6 Data validation
    • Data validation
  • 13.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 13.8 Data synthesis
    • Data synthesis
  • 13.9 360 degree market analysis
    • 360 degree market analysis
  • 13.10 List of abbreviations
    • List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Application
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Company Market Positioning
  • Exhibits10: Parent Market
  • Exhibits11: Data Table on - Parent Market
  • Exhibits12: Market characteristics analysis
  • Exhibits13: Value Chain Analysis
  • Exhibits14: Offerings of companies included in the market definition
  • Exhibits15: Market segments
  • Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits20: Historic Market Size - Data Table on Global Orthobiologics Market 2018 - 2022 ($ million)
  • Exhibits21: Historic Market Size - Application Segment 2018 - 2022 ($ million)
  • Exhibits22: Historic Market Size - Product Segment 2018 - 2022 ($ million)
  • Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
  • Exhibits25: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits31: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits32: Chart on Application - Market share 2023-2028 (%)
  • Exhibits33: Data Table on Application - Market share 2023-2028 (%)
  • Exhibits34: Chart on Comparison by Application
  • Exhibits35: Data Table on Comparison by Application
  • Exhibits36: Chart on Spinal fusion - Market size and forecast 2023-2028 ($ million)
  • Exhibits37: Data Table on Spinal fusion - Market size and forecast 2023-2028 ($ million)
  • Exhibits38: Chart on Spinal fusion - Year-over-year growth 2023-2028 (%)
  • Exhibits39: Data Table on Spinal fusion - Year-over-year growth 2023-2028 (%)
  • Exhibits40: Chart on Reconstructive surgery - Market size and forecast 2023-2028 ($ million)
  • Exhibits41: Data Table on Reconstructive surgery - Market size and forecast 2023-2028 ($ million)
  • Exhibits42: Chart on Reconstructive surgery - Year-over-year growth 2023-2028 (%)
  • Exhibits43: Data Table on Reconstructive surgery - Year-over-year growth 2023-2028 (%)
  • Exhibits44: Chart on Trauma repair - Market size and forecast 2023-2028 ($ million)
  • Exhibits45: Data Table on Trauma repair - Market size and forecast 2023-2028 ($ million)
  • Exhibits46: Chart on Trauma repair - Year-over-year growth 2023-2028 (%)
  • Exhibits47: Data Table on Trauma repair - Year-over-year growth 2023-2028 (%)
  • Exhibits48: Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibits49: Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibits50: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits51: Data Table on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits52: Market opportunity by Application ($ million)
  • Exhibits53: Data Table on Market opportunity by Application ($ million)
  • Exhibits54: Chart on Product - Market share 2023-2028 (%)
  • Exhibits55: Data Table on Product - Market share 2023-2028 (%)
  • Exhibits56: Chart on Comparison by Product
  • Exhibits57: Data Table on Comparison by Product
  • Exhibits58: Chart on Bone graft substitutes - Market size and forecast 2023-2028 ($ million)
  • Exhibits59: Data Table on Bone graft substitutes - Market size and forecast 2023-2028 ($ million)
  • Exhibits60: Chart on Bone graft substitutes - Year-over-year growth 2023-2028 (%)
  • Exhibits61: Data Table on Bone graft substitutes - Year-over-year growth 2023-2028 (%)
  • Exhibits62: Chart on Viscosupplementation - Market size and forecast 2023-2028 ($ million)
  • Exhibits63: Data Table on Viscosupplementation - Market size and forecast 2023-2028 ($ million)
  • Exhibits64: Chart on Viscosupplementation - Year-over-year growth 2023-2028 (%)
  • Exhibits65: Data Table on Viscosupplementation - Year-over-year growth 2023-2028 (%)
  • Exhibits66: Chart on Stem cells - Market size and forecast 2023-2028 ($ million)
  • Exhibits67: Data Table on Stem cells - Market size and forecast 2023-2028 ($ million)
  • Exhibits68: Chart on Stem cells - Year-over-year growth 2023-2028 (%)
  • Exhibits69: Data Table on Stem cells - Year-over-year growth 2023-2028 (%)
  • Exhibits70: Market opportunity by Product ($ million)
  • Exhibits71: Data Table on Market opportunity by Product ($ million)
  • Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits73: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits74: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits75: Chart on Geographic comparison
  • Exhibits76: Data Table on Geographic comparison
  • Exhibits77: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits78: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits79: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits80: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits81: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits82: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits83: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits84: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits85: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits86: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits87: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits88: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits93: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits94: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits95: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits96: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits97: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits99: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits100: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits101: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits102: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits103: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits104: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits105: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits106: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits107: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits108: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits109: Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits110: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits111: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits112: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits113: Market opportunity By Geographical Landscape ($ million)
  • Exhibits114: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits115: Impact of drivers and challenges in 2023 and 2028
  • Exhibits116: Overview on criticality of inputs and factors of differentiation
  • Exhibits117: Overview on factors of disruption
  • Exhibits118: Impact of key risks on business
  • Exhibits119: Companies covered
  • Exhibits120: Matrix on companies position and classification
  • Exhibits121: Advanced Medical Solutions Group Plc - Overview
  • Exhibits122: Advanced Medical Solutions Group Plc - Business segments
  • Exhibits123: Advanced Medical Solutions Group Plc - Key news
  • Exhibits124: Advanced Medical Solutions Group Plc - Key offerings
  • Exhibits125: Advanced Medical Solutions Group Plc - Segment focus
  • Exhibits126: Anika Therapeutics Inc. - Overview
  • Exhibits127: Anika Therapeutics Inc. - Product / Service
  • Exhibits128: Anika Therapeutics Inc. - Key news
  • Exhibits129: Anika Therapeutics Inc. - Key offerings
  • Exhibits130: Arthrex Inc. - Overview
  • Exhibits131: Arthrex Inc. - Product / Service
  • Exhibits132: Arthrex Inc. - Key offerings
  • Exhibits133: Bioventus LLC - Overview
  • Exhibits134: Bioventus LLC - Business segments
  • Exhibits135: Bioventus LLC - Key news
  • Exhibits136: Bioventus LLC - Key offerings
  • Exhibits137: Bioventus LLC - Segment focus
  • Exhibits138: Globus Medical Inc. - Overview
  • Exhibits139: Globus Medical Inc. - Product / Service
  • Exhibits140: Globus Medical Inc. - Key offerings
  • Exhibits141: Institut Straumann AG - Overview
  • Exhibits142: Institut Straumann AG - Business segments
  • Exhibits143: Institut Straumann AG - Key news
  • Exhibits144: Institut Straumann AG - Key offerings
  • Exhibits145: Institut Straumann AG - Segment focus
  • Exhibits146: Johnson and Johnson Services Inc. - Overview
  • Exhibits147: Johnson and Johnson Services Inc. - Business segments
  • Exhibits148: Johnson and Johnson Services Inc. - Key news
  • Exhibits149: Johnson and Johnson Services Inc. - Key offerings
  • Exhibits150: Johnson and Johnson Services Inc. - Segment focus
  • Exhibits151: Medtronic Plc - Overview
  • Exhibits152: Medtronic Plc - Business segments
  • Exhibits153: Medtronic Plc - Key news
  • Exhibits154: Medtronic Plc - Key offerings
  • Exhibits155: Medtronic Plc - Segment focus
  • Exhibits156: Nuvasive Inc. - Overview
  • Exhibits157: Nuvasive Inc. - Business segments
  • Exhibits158: Nuvasive Inc. - Key offerings
  • Exhibits159: Nuvasive Inc. - Segment focus
  • Exhibits160: Orthofix Medical Inc. - Overview
  • Exhibits161: Orthofix Medical Inc. - Business segments
  • Exhibits162: Orthofix Medical Inc. - Key news
  • Exhibits163: Orthofix Medical Inc. - Key offerings
  • Exhibits164: Orthofix Medical Inc. - Segment focus
  • Exhibits165: OrthoPediatrics Corp. - Overview
  • Exhibits166: OrthoPediatrics Corp. - Business segments
  • Exhibits167: OrthoPediatrics Corp. - Key offerings
  • Exhibits168: OrthoPediatrics Corp. - Segment focus
  • Exhibits169: ROYAL BIOLOGICS - Overview
  • Exhibits170: ROYAL BIOLOGICS - Product / Service
  • Exhibits171: ROYAL BIOLOGICS - Key offerings
  • Exhibits172: RTI Surgical Inc. - Overview
  • Exhibits173: RTI Surgical Inc. - Product / Service
  • Exhibits174: RTI Surgical Inc. - Key offerings
  • Exhibits175: Smith and Nephew plc - Overview
  • Exhibits176: Smith and Nephew plc - Business segments
  • Exhibits177: Smith and Nephew plc - Key news
  • Exhibits178: Smith and Nephew plc - Key offerings
  • Exhibits179: Smith and Nephew plc - Segment focus
  • Exhibits180: Stryker Corp. - Overview
  • Exhibits181: Stryker Corp. - Business segments
  • Exhibits182: Stryker Corp. - Key news
  • Exhibits183: Stryker Corp. - Key offerings
  • Exhibits184: Stryker Corp. - Segment focus
  • Exhibits185: Inclusions checklist
  • Exhibits186: Exclusions checklist
  • Exhibits187: Currency conversion rates for US$
  • Exhibits188: Research methodology
  • Exhibits189: Information sources
  • Exhibits190: Data validation
  • Exhibits191: Validation techniques employed for market sizing
  • Exhibits192: Data synthesis
  • Exhibits193: 360 degree market analysis
  • Exhibits194: List of abbreviations